Knee Replacement Risk of Death: What You Need to Know

The risk of dying within 30 days of a knee replacement is roughly 1 to 2 in every 1,000 patients, and that number has fallen substantially over the past few decades. A large meta-analysis pooling data from over 1.8 million procedures placed the 30-day mortality rate at about 0.14%, while the 90-day rate was around 0.35%.¹ Those numbers make elective knee replacement one of the safest major surgeries performed today, but they are averages, and your personal risk depends on a cluster of factors worth understanding before you schedule a date.

What the Short-Term Numbers Actually Look Like

Studies measuring mortality at different time points after knee replacement converge on a consistent picture. The risk of death in the first week is very small, roughly 0.1%. By 30 days, it rises to somewhere between 0.1% and 0.3%, depending on the population studied and the era of the data. By 90 days, most estimates land between 0.2% and 0.5%.² One study from the UK reported slightly higher figures, with 30-day and 90-day mortality of about 0.3% and 0.6%, respectively, though these included a comparison group of patients on waiting lists whose background mortality was lower.³

To put that into perspective, the risk of a healthy adult dying in a given 90-day stretch from everyday causes is not zero. The surgery adds a small, real, but temporary bump to that background risk, concentrated mostly in the first two weeks. The vast majority of patients who get through the first month without complications face mortality rates that quickly return to what they would have been without the operation.

How Much Safer Has Knee Replacement Become

One of the most striking stories in orthopedic surgery is how dramatically mortality after joint replacement has dropped. Before 1980, the death rate following major hip and knee surgery was around 1.15%. By the 2000s, that figure had fallen to about 0.24%, a relative reduction of nearly 79%.⁴ Roughly three-quarters of that improvement came from better overall surgical and hospital care rather than just blood-clot-prevention drugs, meaning improvements in anesthesia, monitoring, early mobilization, and infection control all played major roles.

The trend continued after 2000. A national cohort study from England and Wales tracked nearly 470,000 primary knee replacements done between 2003 and 2011 and found that 45-day mortality dropped from 0.37% to 0.20% over that period, even after adjusting for patients getting older and sicker.⁵ A separate systematic review using meta-regression estimated that by 2015, the 30-day mortality had fallen to about 0.10% and the 90-day mortality to about 0.19%.⁶ If you are having knee replacement surgery today, you are benefiting from decades of accumulated improvements in how the procedure is done and how patients are managed afterward.

The Leading Causes of Death After Knee Replacement

When deaths do occur, they tend to cluster around a few causes. Understanding them helps clarify where the risk actually sits.

Heart Attacks and Cardiac Events

Cardiac complications are the most common serious threat. Among more than 46,000 patients who had hip or knee replacements, the cardiac complication rate at 30 days was about 0.33%. Of those who suffered a heart attack or cardiac arrest, nearly 80% had the event within the first seven days after surgery.⁷ The strongest predictors were age over 80, high blood pressure requiring medication, and a history of heart disease. The stress of surgery on the cardiovascular system is the main driver, which is why pre-operative cardiac screening matters so much for patients with existing risk factors.

Blood Clots

Pulmonary embolism, where a blood clot travels to the lungs, has historically been the most feared surgical complication. Modern blood-thinning protocols have pushed the rate of symptomatic pulmonary embolism after knee replacement down to roughly 0.3% to 1.5%, with fatal cases occurring in up to about 0.1% of patients.⁸ One consecutive series of over 4,200 joint replacements recorded a fatal pulmonary embolism rate of 0.07%, leading the researchers to conclude that with modern practice, elective joint replacement should no longer be considered a high-risk procedure for this complication.⁹

The choice of blood-clot-prevention drug has evolved as well. A large randomized trial found that aspirin was not meaningfully different from rivaroxaban, a more expensive prescription blood thinner, in preventing blood clots after joint replacement. Clot rates were under 1% in both groups, and major bleeding complications were similarly low.¹⁰ This finding has broadened the options available, especially for patients who want a simpler, cheaper regimen.

Infection

Joint infection after knee replacement is uncommon, but when it occurs, it dramatically changes the risk profile. A meta-analysis of outcomes after infected knee replacements found an overall mortality rate of about 13% over a mean follow-up of roughly four years, with mortality reaching about 5% at three months and 7% at one year.¹¹ Among patients who develop sepsis, which is the body’s severe inflammatory response to infection, the mortality rate jumps to about 3.7%, compared with 0.1% in patients who do not develop sepsis.¹² Infection is rare as a cause of death after a straightforward primary knee replacement, but it becomes a central concern when revision surgery is needed.

Who Faces Higher Risk

The average mortality numbers are reassuring, but they smooth over wide variation between patients. Certain factors consistently raise the risk, and knowing them helps you and your surgeon make informed decisions about timing and preparation.

Older age is the single strongest predictor. Risk climbs steadily with each decade, and patients over 80 face meaningfully higher odds of cardiac events and death than those in their 60s.¹³ Male sex also consistently shows up as a risk factor across studies, though the reasons are not fully understood and probably relate to men having higher baseline rates of cardiovascular disease.

Specific medical conditions that raise risk include congestive heart failure, prior heart attack, cerebrovascular disease (such as prior stroke), kidney disease, and moderate or severe liver disease. In one large Korean database study, severe liver disease carried the highest hazard for 90-day death, with kidney disease and heart failure also showing substantially elevated risk.¹³ Other studies have added preoperative anemia, poor walking ability before surgery, and the need for walking aids as markers of frailty that predict worse outcomes.¹⁴

The practical takeaway is that preoperative optimization matters. Getting blood pressure, blood sugar, and anemia under better control before surgery, losing weight if possible, and building strength and walking endurance can all shift a patient’s risk profile in the right direction. None of these conditions are absolute barriers to surgery, but they change the conversation about whether to proceed and how much monitoring is appropriate.

Revision Surgery Carries Higher Risk

A revision knee replacement, where part or all of the original implant is removed and replaced, is a bigger operation than the primary procedure. The 30-day mortality rate after revision is roughly twice as high as after a first-time knee replacement, about 0.36% compared with 0.18% in the same timeframe.¹⁵ But the reason for the revision matters enormously. When the revision is done electively for a worn-out or loosened implant, the 90-day mortality is around 0.44%, which is comparable to primary surgery. When the revision is done for infection, that rate jumps to about 2%. And when the revision is for a fracture around the implant, the 90-day mortality reaches roughly 5%.¹⁶

A study comparing septic and aseptic revision found that mortality after revision for infection was six times higher than revision for other reasons.¹⁷ This underscores why surgeons treat joint infection aggressively and why prevention of infection at the time of the first surgery is so important.

Both Knees at Once Versus One at a Time

Some patients with arthritis in both knees want to have both replaced during a single trip to the operating room, avoiding a second recovery period. The data shows this comes with a tradeoff. Simultaneous bilateral knee replacement has roughly double the odds of mortality compared with doing one knee at a time, along with higher rates of pulmonary embolism and cardiac complications.¹⁸ The absolute risk is still low, but the relative increase is consistent enough that many surgeons reserve bilateral surgery for younger, healthier patients and space out the procedures for those with significant medical conditions.

Does the Type of Anesthesia Matter

You will usually be offered a choice between general anesthesia (fully asleep) and spinal anesthesia (numb from the waist down but awake or sedated). The evidence here is mixed but leans in one direction. One older study reported a notably lower 30-day mortality rate with spinal anesthesia compared with general anesthesia.¹⁹ However, a larger and more recent Canadian retrospective study found no statistically significant difference in mortality at 30, 60, or 90 days between the two approaches for knee replacement patients.²⁰

Where spinal anesthesia does appear to have an edge is in reducing the odds of blood clots in the legs. A 2024 analysis found that patients receiving general anesthesia for knee replacement had roughly twice the odds of developing a deep vein thrombosis within 30 days, though no other differences in outcomes were found.²¹ For most patients, the anesthesia choice should be guided by individual medical history and the anesthesiologist’s recommendation rather than by fear of one method being dramatically more dangerous than the other.

Where You Have Your Surgery Matters

Hospital and surgeon experience have a measurable effect on outcomes. Patients treated in hospitals performing more than 200 knee replacements a year had about a 26% lower chance of experiencing any serious adverse outcome, including death, pneumonia, pulmonary embolism, heart attack, or deep infection, compared with patients at hospitals performing 25 or fewer annually. A similar volume-outcome relationship held for individual surgeons: those performing more than 50 knee replacements a year in Medicare patients saw fewer complications than surgeons doing 12 or fewer.²²

Data from the American Joint Replacement Registry reinforced this, finding that the combination of a low-volume surgeon working in a low-volume hospital was associated with nearly 50% higher odds of 90-day mortality compared with higher-volume settings.²³ This does not mean a low-volume hospital is inherently unsafe, but it does suggest that asking about your surgeon’s caseload and the hospital’s joint replacement volume is a reasonable part of your pre-surgery research.

Outpatient Knee Replacement and Same-Day Discharge

The trend toward same-day or next-day discharge after knee replacement has accelerated in recent years, raising natural questions about safety. A systematic review with meta-analysis found no significant differences in overall complication or readmission rates between outpatient and inpatient knee replacement patients.²⁴ But there is a caveat: these studies generally enroll carefully selected patients who are younger, healthier, and have strong support at home. One earlier analysis found that outpatient and short-stay knee replacement groups actually had higher revision, readmission, and mortality rates when compared with standard-stay patients in a broader, less-selected population.²⁵ The lesson is that outpatient surgery can be safe for the right patient, but the selection criteria matter. If your surgeon suggests an overnight stay, it is usually because your profile warrants the extra monitoring.

Racial and Socioeconomic Disparities in Outcomes

Research on whether outcomes differ by race has produced results that deserve attention. One regional database study found no significant difference in 30-day complications by racial group after adjusting for other factors, though there was a trend toward higher one-year mortality for Black patients that did not reach statistical significance.²⁶ A larger national study, however, found significantly higher mortality rates for Black, Native American, and mixed-race patients after knee replacement.²⁷ The disparities are likely driven by differences in rates of comorbid conditions, access to high-volume surgical centers, and broader systemic factors in healthcare delivery rather than by any inherent biological difference in surgical risk.

Long-Term Survival After Knee Replacement

One of the more reassuring findings in the knee replacement literature is that people who survive the initial surgical period tend to live as long as, or even longer than, the general population. A study tracking long-term outcomes concluded that patients undergoing knee replacement can expect similar life expectancy to the general population, with about two-thirds surviving at least 15 years.²⁸ A 2024 Korean study went further, finding that knee replacement patients actually had a lower standardized mortality ratio than the general population, meaning they were dying at a lower rate than expected for their age. The effect was strongest in patients in their 70s and those 80 and older.²⁹

This likely reflects a combination of selection bias and genuine health benefits. People healthy enough to be approved for elective surgery are healthier than the average person their age to begin with. But there is also evidence that the surgery itself improves long-term health by enabling patients to be more physically active. Research has linked knee replacement in osteoarthritis patients to a lower risk of subsequent serious cardiovascular events, potentially because the procedure restores the ability to walk and exercise, which in turn improves blood pressure, blood sugar, and weight management.³⁰ Moderate physical activity like brisk walking a few days a week benefits people who have established risk factors for heart disease, exactly the profile of many knee replacement patients.³¹

Bone Cement Reactions During Surgery

One risk factor that most patients never hear about is bone cement implantation syndrome. During knee replacement, cement is commonly used to secure the implant to bone. In rare cases, pressurizing cement into the bone canal causes a sudden cardiovascular reaction involving a drop in blood pressure and oxygen levels. Patients who experience a severe form of this syndrome during surgery are more than three times as likely to die within 30 days compared with patients who do not.³² Severe cases are uncommon, and anesthesiologists are trained to recognize and manage the reaction, but it is one of the reasons careful intraoperative monitoring exists. Cementless implant designs are becoming more common in knee replacement, though whether they fully eliminate this risk while maintaining long-term implant durability is still being studied.

What You Can Do to Lower Your Risk

Much of the risk reduction is in your hands, or at least within your influence. Getting physically stronger before surgery improves recovery and reduces complications. If you smoke, quitting even a few weeks beforehand improves wound healing and reduces blood clot risk. Managing diabetes, blood pressure, and weight all shift the odds. Choosing a surgeon and hospital with a high volume of joint replacements is one of the most evidence-backed decisions you can make. Discussing anesthesia options, blood clot prevention, and early mobilization plans with your surgical team rounds out the preparation.

After surgery, the first two weeks carry the highest risk. Getting up and moving early, wearing compression stockings if recommended, taking your blood thinner as prescribed, and watching for warning signs like chest pain, sudden shortness of breath, or calf swelling that worsens are all practical steps. Most patients sail through without any serious problems, but knowing the warning signs means faster treatment in the rare event something goes wrong.